Inventor
DIAMOND DON J
US38 patents
⚠️ This page may combine multiple inventors who share the name “DIAMOND DON J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOPE CITY
37 patentsUS6843992B2Jan 18, 2005
Immuno-reactive peptide CTL epitopes of human cytomegalovirus
HOPE CITY32 citations96
US9453227B2Sep 27, 2016
Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
HOPE CITY68 citations93
US6733973B2May 11, 2004
Diagnostic reagents for human cytomegalovirus and methods of use
HOPE CITY20 citations92
US6727093B2Apr 27, 2004
HCMV-reactive T cells and uses therefor
HOPE CITY13 citations92
US6726910B2Apr 27, 2004
Immuno-reactive peptide CTL epitopes of human cytomegalovirus
HOPE CITY19 citations92
US6632435B1Oct 14, 2003
CTL epitope analogs
HOPE CITY18 citations92
US6562345B1May 13, 2003
Immuno-reactive peptide CTL epitopes of human cytomegalovirus
HOPE CITY15 citations92
US10100314B2Oct 16, 2018
Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
HOPE CITY13 citations91
US7256037B2Aug 14, 2007
Modified vaccinia Ankara expressing p53 in cancer immunotherapy
HOPE CITY23 citations90
US6770749B2Aug 3, 2004
P53-specific T cell receptor for adoptive immunotherapy
HOPE CITY46 citations90
US11116834B2Sep 14, 2021
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy
HOPE CITY10 citations85
US6544521B2Apr 8, 2003
Immunoreactive peptide CTL epitopes of human cytomegalovirus pp150
HOPE CITY16 citations84
US10376575B2Aug 13, 2019
MVA vaccine for delivery of a UL128 complex and preventing CMV infection
HOPE CITY3 citations83
US9931395B2Apr 3, 2018
MVA vaccine for delivery of a UL128 complex and preventing CMV infection
HOPE CITY6 citations83
US11141492B2Oct 12, 2021
Anticancer combinations
HOPE CITY7 citations82
US10961538B2Mar 30, 2021
Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
HOPE CITY7 citations82
US10584339B2Mar 10, 2020
Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
HOPE CITY9 citations82
US6951651B2Oct 4, 2005
CTL epitope analogs
HOPE CITY7 citations74
US10596254B2Mar 24, 2020
Synthetic conjugate of CpG DNA and T-help/CTL peptide
HOPE CITY1 citations73
US9974854B2May 22, 2018
Synthetic conjugate of CpG DNA and T-help/CTL peptide
HOPE CITY3 citations73
US12161714B2Dec 10, 2024
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy
HOPE CITY1 citations72
US11690908B2Jul 4, 2023
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy
HOPE CITY3 citations72
US12478672B2Nov 25, 2025
Use of triplex CMV vaccine in CAR T cell therapy
HOPE CITY0 citations62
US12337032B2Jun 24, 2025
Genetically stable recombinant modified vaccinia Ankara (RMVA) vaccines and methods of preparation thereof
HOPE CITY0 citations62
US12150987B2Nov 26, 2024
MVA vaccine for delivery of a UL128 complex and preventing CMV infection
HOPE CITY0 citations62
US11844833B2Dec 19, 2023
Expression system for expressing herpesvirus glycoprotein complexes
HOPE CITY0 citations62
US11717568B2Aug 8, 2023
MVA vaccine for delivery of a UL128 complex and preventing CMV infection
HOPE CITY0 citations62
US11602554B2Mar 14, 2023
P53-targeting vaccines and pd-1 pathway inhibitors and methods of use thereof
HOPE CITY0 citations62
US11389529B2Jul 19, 2022
Expression system for expressing herpesvirus glycoprotein complexes
HOPE CITY0 citations62
US10987420B2Apr 27, 2021
Synthetic conjugate of CpG DNA and T-help/CTL peptide
HOPE CITY0 citations62
US11384137B2Jul 12, 2022
MVA-gH/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereof
HOPE CITY0 citations58
US12054736B2Aug 6, 2024
Genetically modified recombinant vaccinia ankara (RMVA) vaccines of improved stability and methods of preparation thereof
HOPE CITY0 citations55
US12527858B2Jan 20, 2026
MVA vectors for expressing multiple cytomegalovirus (CMV) antigens and use thereof
HOPE CITY0 citations51
US10842864B2Nov 24, 2020
MVA vaccine for delivery of a UL128 complex and preventing CMV infection
HOPE CITY0 citations51
US7563448B2Jul 21, 2009
Modified vaccinia ankara expressing P53 in cancer immunotherapy
HOPE CITY1 citations49
US12584146B2Mar 24, 2026
Synthetic modified vaccinia Ankara (SMVA) based coronavirus vaccines
HOPE CITY0 citations47
US10487139B2Nov 26, 2019
MVA-gh/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereof
HOPE CITY0 citations47